These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21296118)

  • 41. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.
    Goldblatt D; Southern J; Ashton L; Richmond P; Burbidge P; Tasevska J; Crowley-Luke A; Andrews N; Morris R; Borrow R; Cartwright K; Miller E
    Pediatr Infect Dis J; 2006 Apr; 25(4):312-9. PubMed ID: 16567982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response of steroid-treated former preterm infants to a single dose of meningococcal C conjugate vaccine.
    Clarke P; Robinson MJ; Ahmad I; Bedford-Russell AR; Connell JE; Powell PJ; Heath PT
    Vaccine; 2006 Apr; 24(16):3273-8. PubMed ID: 16472548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
    Siber GR; Chang I; Baker S; Fernsten P; O'Brien KL; Santosham M; Klugman KP; Madhi SA; Paradiso P; Kohberger R
    Vaccine; 2007 May; 25(19):3816-26. PubMed ID: 17368878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population.
    Leach AJ; Morris PS; Mackenzie G; McDonnell J; Balloch A; Carapetis J; Tang M
    Vaccine; 2008 Jul; 26(31):3885-91. PubMed ID: 18562052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.
    Dagan R; Givon-Lavi N; Fraser D; Lipsitch M; Siber GR; Kohberger R
    J Infect Dis; 2005 Aug; 192(3):367-76. PubMed ID: 15995949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
    Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
    Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.
    Balmer P; Borrow R; Findlow J; Warrington R; Frankland S; Waight P; George R; Andrews N; Miller E
    Clin Vaccine Immunol; 2007 Nov; 14(11):1442-50. PubMed ID: 17881503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.
    Sikkema DJ; Friedman KE; Corsaro B; Kimura A; Hildreth SW; Madore DV; Quataert SA
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):764-8. PubMed ID: 10973451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective potency of recombinant meningococcal IgA1 protease and its structural derivatives upon animal invasion with meningococcal and pneumococcal infections.
    Kotelnikova O; Alliluev A; Zinchenko A; Zhigis L; Prokopenko Y; Nokel E; Razgulyaeva O; Zueva V; Tokarskaya M; Yastrebova N; Gordeeva E; Melikhova T; Kaliberda E; Rumsh L
    Microbes Infect; 2019; 21(7):336-340. PubMed ID: 30797878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplants.
    Gattringer R; Winkler H; Roedler S; Jaksch P; Herkner H; Burgmann H
    Transpl Infect Dis; 2011 Oct; 13(5):540-4. PubMed ID: 21489090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates.
    Voysey M; Pollard AJ; Sadarangani M; Fanshawe TR
    Vaccine; 2017 Oct; 35(43):5850-5857. PubMed ID: 28935471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.
    O'Brien KL; Moulton LH; Reid R; Weatherholtz R; Oski J; Brown L; Kumar G; Parkinson A; Hu D; Hackell J; Chang I; Kohberger R; Siber G; Santosham M
    Lancet; 2003 Aug; 362(9381):355-61. PubMed ID: 12907008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of individual conjugate dose on immunogenicity of type 6B pneumococcal polysaccharide-N. meningitidis outer membrane protein complex conjugate vaccines in infant rhesus monkeys.
    McNeely TB; Liu X; Bringman T; Donnelly JJ
    Vaccine; 2000 Jun; 18(25):2808-16. PubMed ID: 10812223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination vaccine against invasive meningococcal B and pneumococcal infections: potential epidemiological and economic impact in the Netherlands.
    Bos JM; Rümke HC; Welte R; Spanjaard L; van Alphen L; Postma MJ
    Pharmacoeconomics; 2006; 24(2):141-53. PubMed ID: 16460135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.
    Schwarz TF; Flamaing J; Rümke HC; Penzes J; Juergens C; Wenz A; Jayawardene D; Giardina P; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2011 Jul; 29(32):5195-202. PubMed ID: 21619909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pneumococcal conjugate vaccines in Asia and the Pacific. Singapore, 9-11 October 2000. Report of an Asia Pacific Board Advisory Meeting.
    Vaccine; 2001 Sep; 19(32):4579-87. PubMed ID: 11729814
    [No Abstract]   [Full Text] [Related]  

  • 57. Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?
    Tozzi AE; Azzari C; Bartolozzi G; Esposito S; Fara GM; Giudice ML
    Hum Vaccin; 2007; 3(6):252-9. PubMed ID: 17881905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine.
    Bologa M; Kamtchoua T; Hopfer R; Sheng X; Hicks B; Bixler G; Hou V; Pehlic V; Yuan T; Gurunathan S
    Vaccine; 2012 Dec; 30(52):7461-8. PubMed ID: 23123106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults.
    Scott D; Ruckle J; Dar M; Baker S; Kondoh H; Lockhart S
    Pediatr Int; 2008 Jun; 50(3):295-9. PubMed ID: 18533940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine.
    Shahid NS; Steinhoff MC; Hoque SS; Begum T; Thompson C; Siber GR
    Lancet; 1995 Nov; 346(8985):1252-7. PubMed ID: 7475716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.